Precision Biosciences (DTIL) Total Debt (2021 - 2025)
Historic Total Debt for Precision Biosciences (DTIL) over the last 4 years, with Q3 2025 value amounting to $22.4 million.
- Precision Biosciences' Total Debt rose 43.09% to $22.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.4 million, marking a year-over-year increase of 43.09%. This contributed to the annual value of $22.3 million for FY2024, which is 40.6% down from last year.
- Latest data reveals that Precision Biosciences reported Total Debt of $22.4 million as of Q3 2025, which was up 43.09% from $22.4 million recorded in Q2 2025.
- In the past 5 years, Precision Biosciences' Total Debt ranged from a high of $22.5 million in Q2 2024 and a low of $2.4 million during Q2 2021
- In the last 4 years, Precision Biosciences' Total Debt had a median value of $22.3 million in 2025 and averaged $19.0 million.
- Per our database at Business Quant, Precision Biosciences' Total Debt skyrocketed by 79.31% in 2024 and then crashed by 62.24% in 2025.
- Precision Biosciences' Total Debt (Quarter) stood at $2.5 million in 2021, then skyrocketed by 813.28% to $22.4 million in 2023, then fell by 0.41% to $22.3 million in 2024, then increased by 0.24% to $22.4 million in 2025.
- Its Total Debt was $22.4 million in Q3 2025, compared to $22.4 million in Q2 2025 and $22.3 million in Q1 2025.